Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia (Q26785828)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia |
scientific article |
Statements
7 references
13 March 2019
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia (English)
0 references
4 September 2015
7 references
13 March 2019
3 April 2019
27 November 2019
13 December 2019
14 September 2020
25 January 2021
20 October 2022
7 references
13 March 2019
3 April 2019
27 November 2019
13 December 2019
14 September 2020
25 January 2021
20 October 2022
8
0 references
1
0 references
104
0 references
7 references
13 March 2019
3 April 2019
27 November 2019
13 December 2019
14 September 2020
25 January 2021
20 October 2022
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference